Evidence map›Paper›PMID 40722744›Full record

ArticleBiomedicines2025

Serum Levels of N

Rositsa Tsekovska, Evan Gatev, Roumyana Mironova, Simona Kerezieva, Siyana Ilieva, Teodora Ilieva, Bilyana Vasileva, Toshimitsu Niwa, Daniela Popova, Vasil Vasilev

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Identification of Bioactive Medium Chain Fatty Acids (CAntioxidants (Basel, Switzerland) · 2026
    Article
  4. High glucose enhances NScientific reports · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rositsa TsekovskaRoumen Tsanev Institute of Molecular Biology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0001-5431-5743
Evan GatevRoumen Tsanev Institute of Molecular Biology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Roumyana MironovaRoumen Tsanev Institute of Molecular Biology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Simona KerezievaUniversity Hospital "Tsaritsa Yoanna-ISUL", Medical University-Sofia, 1431 Sofia, Bulgaria.ORCID 0000-0002-1227-6974
Siyana IlievaUniversity Hospital "Tsaritsa Yoanna-ISUL", Medical University-Sofia, 1431 Sofia, Bulgaria.
Teodora IlievaUniversity Hospital "Tsaritsa Yoanna-ISUL", Medical University-Sofia, 1431 Sofia, Bulgaria.
Bilyana VasilevaUniversity Hospital "Tsaritsa Yoanna-ISUL", Medical University-Sofia, 1431 Sofia, Bulgaria.
Toshimitsu NiwaFaculty of Medical Sciences, Shubun University, Ichinomiya 491-0938, Aichi, Japan.ORCID 0000-0001-8832-498X
Daniela PopovaUniversity Hospital "Tsaritsa Yoanna-ISUL", Medical University-Sofia, 1431 Sofia, Bulgaria.
Vasil VasilevUniversity Hospital "Tsaritsa Yoanna-ISUL", Medical University-Sofia, 1431 Sofia, Bulgaria.

Funding

Bulgarian Science Fund KP-06-N61-3/14Dec2022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced glycation end productschronic kidney diseasediabetes mellitusglycoxidationNε-(carboxymethyl)-lysine

Identifiers

PMID40722744
PMCPMC12292756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.